Efficacy and Safety of Nonfluoroscopic Approach During Catheter Ablation of Ventricular Tachycardias

Huseynli, E G; Sapelnikov, O.V.; Amanatova, V.A.; Ardus, D.F.; Khachirov, M R; Grishin, Igor; Cherkashin, D. I.; Саидова, М. А.; Стукалова, О. В.; Шлевков, Н. Б.; Uskach, T. M.; Акчурин, Р. С.

doi:10.18087/cardio.2023.3.n2243

Cited by 1 publication

(2 citation statements)

References 19 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, our study noted a non-significant trend toward reduced mortality in the catheter ablation group. While not statistically significant, this trend invites further investigation into the potential for catheter ablation to confer long-term survival benefits, a question that has been previously raised but remains unresolved in the literature [ 7 , 8 ]. The complexity of ARVC’s progression and the multifactorial nature of arrhythmic risk underscore the need for long-term, prospective studies to fully elucidate the impact of catheter ablation on survival.…”

Section: Discussionmentioning

confidence: 99%

“…The advent of catheter ablation as a treatment for controlling ventricular arrhythmias has been a significant development, offering a new avenue for reducing arrhythmia recurrence and improving patient outcomes. However, comprehensive evaluations comparing the efficacy and safety of catheter ablation to conventional management methods in ARVC patients are notably lacking, creating a gap in our collective knowledge [5][6][7].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluating Catheter Ablation Versus Conventional Management for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy: A Five-Year Retrospective Cohort Study

Khan,

Memon,

Sajjad

2024

Cureus

View full text Add to dashboard Cite

Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a challenging genetic disorder marked by ventricular arrhythmias and sudden cardiac death, particularly in athletes and young adults. Despite its clinical significance, the relative effectiveness and safety of catheter ablation versus conventional management in ARVC are not fully delineated. Objective This study evaluates the efficacy and safety of catheter ablation compared to conventional management in reducing ventricular arrhythmias and improving patient outcomes over five years in ARVC patients. Methods In a retrospective cohort design at Lady Reading Hospital, Peshawar, we analyzed 120 ARVC patients from January 2018 to December 2023. Patients were divided into two groups: those undergoing catheter ablation and those receiving conventional management. Primary outcomes assessed were recurrence of ventricular arrhythmias, procedural complications, hospitalization duration, and mortality rates. Logistic regression was adjusted for demographics and clinical variables. Results Catheter ablation significantly lowered the recurrence of ventricular arrhythmias (20% vs. 55%, p<0.01) and reduced hospital stay duration (4 ± 2 days vs. 7 ± 3 days, p<0.05). A trend toward reduced five-year mortality was observed in the catheter ablation group (5% vs. 15%, p=0.07). Age, New York Heart Association class, and exercise capacity emerged as significant predictors of outcomes. Conclusions Catheter ablation outperforms conventional management in reducing the recurrence of ventricular arrhythmias and hospitalization in ARVC patients, with a promising trend toward enhanced survival. These findings advocate for personalized management strategies in ARVC, highlighting the necessity for further research to establish the long-term benefits of catheter ablation.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%